InsidersTradesSigma
Follow the 共同药业 stock price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 共同药业 has logged 2 reports. Market capitalisation: €2.6bn. The latest transaction was reported on 17 May 2024 (Sale). Among the most active insiders: 李明磊. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
共同药业 es una empresa especializada en el sector de la salud y farmacéutico, que cotiza en el mercado XSHE. Se centra en el desarrollo y la producción de medicamentos innovadores.